Immutep Limited (ASX:IMM) has announced impressive overall survival results for its lead immunotherapy candidate eftilagimod ...

U.S. drug maker Merck is building a $1 billion facility in Wilmington, Delaware, aimed at increasing domestic production of ...

The All Ordinaries Index (ASX: XAO) is down 0.3% today despite the best efforts of this rocketing ASX All Ords share. Here’s ...

The ASX200 is set to open nearly a third of a percent higher today (0.27%) echoing Wall Street’s positive end to the week, ...

Data-mining and analytics company Palantir (NYSE:PLTR) will be announcing earnings results tomorrow after market hours.